Cargando…

CCL20 promotes lung adenocarcinoma progression by driving epithelial-mesenchymal transition

C-C motif chemokine ligand 20 (CCL20) participates in multiple oncogenic processes, but its role in lung adenocarcinoma (LUAD) is unclear. Herein, we explored the mechanism by which CCL20 works in LUAD progression. We performed bioinformatical analyses based on the complete transcriptome sequencing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Tao, Li, Shuofeng, Xiao, Chu, Tian, He, Zheng, Yujia, Liu, Yu, Li, Chunxiang, He, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295072/ https://www.ncbi.nlm.nih.gov/pubmed/35864953 http://dx.doi.org/10.7150/ijbs.73275

Ejemplares similares

H3K36 trimethylation-mediated biological functions in cancer
por: Xiao, Chu, et al.
Publicado: (2021)

CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells
por: Liu, Yao, et al.
Publicado: (2016)

CDC20 promotes the progression of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Yang, Gang, et al.
Publicado: (2021)

Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma
por: Chen, Xueran, et al.
Publicado: (2017)

NR1D2 Accelerates Hepatocellular Carcinoma Progression by Driving the Epithelial-to-Mesenchymal Transition
por: Tong, Hui, et al.
Publicado: (2020)

Gli is activated and promotes epithelial-mesenchymal transition in human esophageal adenocarcinoma
por: Wang, Lei, et al.
Publicado: (2017)

Epithelial-to-Mesenchymal Transition in Pancreatic Adenocarcinoma
por: Cano, Carla, et al.
Publicado: (2010)

H3K4me3-related lncRNAs signature and comprehensive analysis of H3K4me3 regulating tumor immunity in lung adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2023)

The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating β-catenin
por: Zheng, Yujia, et al.
Publicado: (2022)

LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer
por: Tian, Jing, et al.
Publicado: (2019)

Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas
por: Li, Hui, et al.
Publicado: (2016)

Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
por: Ebbing, Eva A., et al.
Publicado: (2019)

TCTP promotes epithelial–mesenchymal transition in lung adenocarcinoma
por: Sun, Ruilin, et al.
Publicado: (2019)

Epithelial-to-Mesenchymal Transition in the Development and Progression of Adenocarcinoma and Squamous Cell Carcinoma of the Lung
por: Prudkin, Ludmila, et al.
Publicado: (2009)

Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance
por: Palamaris, Kostas, et al.
Publicado: (2021)

DCBLD2 Mediates Epithelial-Mesenchymal Transition-Induced Metastasis by Cisplatin in Lung Adenocarcinoma
por: Chen, Xiaosu, et al.
Publicado: (2021)

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
por: Xiao, Chu, et al.
Publicado: (2022)

ELK1 Promotes Epithelial-Mesenchymal Transition and the Progression of Lung Adenocarcinoma by Upregulating B7-H3
por: Yu, Ting-ting, et al.
Publicado: (2021)

Dusp6 Inhibits Epithelial-mesenchymal Transition in Endometrial Adenocarcinoma Via ERK Signaling Pathway
por: Fan, Ming-Jun, et al.
Publicado: (2019)

Recent progress on the effects of microRNAs and natural products on tumor epithelial–mesenchymal transition
por: He, Shu-Jin, et al.
Publicado: (2017)

Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis
por: Zhao, Zhongquan, et al.
Publicado: (2014)

Human MSCs promotes colorectal cancer epithelial–mesenchymal transition and progression via CCL5/β-catenin/Slug pathway
por: Chen, Ke, et al.
Publicado: (2017)

Oxysterol-Binding Protein 2 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Epithelial-Mesenchymal Transition
por: Huang, Shuai, et al.
Publicado: (2022)

Epithelial-mesenchymal transition in glioblastoma progression
por: IWADATE, YASUO
Publicado: (2016)

Androgen receptor, ccl2, and epithelial-mesenchymal transition: A dangerous affair in the tumor microenvironment
por: Lin, Wen-Jye, et al.
Publicado: (2014)

Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma
por: Steins, Anne, et al.
Publicado: (2019)

Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition
por: Ranieri, Danilo, et al.
Publicado: (2015)

Establishment and Validation of an Interferon-Stimulated Genes (ISGs) Prognostic Signature in Pan-cancer Patients: A Multicenter, Real-world Study
por: Zhou, Zheng, et al.
Publicado: (2022)

CircSTK3 drives the metastasis of colorectal cancer by regulating epithelial-mesenchymal transition
por: Fan, Boyang, et al.
Publicado: (2023)

DCLK1 Drives EGFR-TKI-Acquired Resistance in Lung Adenocarcinoma by Remodeling the Epithelial–Mesenchymal Transition Status
por: Yan, Rui, et al.
Publicado: (2023)

Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma
por: Li, Pei, et al.
Publicado: (2015)

Immune profile of the tumor microenvironment and the identification of a four-gene signature for lung adenocarcinoma
por: Fan, Tao, et al.
Publicado: (2020)

Novel regulatory program for norepinephrine-induced epithelial–mesenchymal transition in gastric adenocarcinoma cell lines
por: Shan, Tao, et al.
Publicado: (2014)

Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition
por: Xiong, Cheng, et al.
Publicado: (2021)

SELENBP1 inhibits progression of colorectal cancer by suppressing epithelial–mesenchymal transition
por: Zhang, Xiaotian, et al.
Publicado: (2022)

Interleukin-8 drives epithelial-mesenchymal transition of human carcinomas
por: Fernando, Romaine I, et al.
Publicado: (2013)

Endothelin‐1 Drives Epithelial‐Mesenchymal Transition in Hypertensive Nephroangiosclerosis
por: Seccia, Teresa M., et al.
Publicado: (2016)

ERK signalling modulates epigenome to drive epithelial to mesenchymal transition
por: Navandar, Mohit, et al.
Publicado: (2017)

USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4
por: Li, Yongmin, et al.
Publicado: (2017)

PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition
por: Yang, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kfnvhkod3p7pflubeed5opo0tc